- Portfolio news
- Show all
Contents
- Deep Bio and PathAI Collaborate to Drive AI-Powered Innovations in Digital Pathology – Integrating Deep Bio’s DeepDx Prostate Algorithm into PathAI’s AISight IMS PlatformDeep Bio "This collaboration allows broader access to our AI-driven...2024-11-20
- Deep Bio and Roche Collaborate to Drive AI-Powered Innovations in Digital PathologySEOUL, SOUTH KOREA, September 9, 2024 /EINPresswire.com/ — Deep Bio,...2024-09-09
- ABION and Deep Bio Sign MOU to Advance AI-Driven Companion Diagnostics and Clinical TrialsSEOUL, SOUTH KOREA, September 5, 2024 /EINPresswire.com/ — ABION today...2024-09-05
- DeepBio becomes first Korean cancer diagnostic A.I. company to win CES Innovation Award-Won the CES Innovation Award for pioneering a new milestone...2023-11-20
- Gencurix gets FDA OK for breast cancer prognosis analysis deviceThe company plans to develop its subsidiary GenoBio's GenoCTC v5...2023-11-08
- Deep Bio Joins CancerX to Revolutionize Cancer Diagnosis and Prognosis with AI ExpertiseSEOUL, South Korea, Nov. 7, 2023 /PRNewswire/ -- Deep Bio,...2023-11-07
- Company news
- Show all
- Publications
- Show all